Acknowledgements The authors wish to acknowledge Humphrey Chukwudi Omeoga, of Thomas BegLey Laboratory, Department of Biological Sciences, State University of New York, at Albany, New York USA for using his licensed accessed BioRender for the diagrams sketching
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor Tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
Interestingly, inhibition of the binding to IKK by using a peptide inhibitor reduced NF-kB activity and thereby senescence in progeroid mice (88)
Qu es la L-carnitina y qu funciones desempea
Van OortFVGreaves-LordKVerhulstFCOrmelJHuizinkAC